# Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer

> **NCT03638193** · NA · UNKNOWN · sponsor: **Shenzhen BinDeBio Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **BIOLOGICAL:** CART-meso cells

## Key facts

- **NCT ID:** NCT03638193
- **Lead sponsor:** Shenzhen BinDeBio Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-11
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-02-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03638193

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03638193, "Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03638193. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*